VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $244,000 | +14.0% | 9,549 | 0.0% | 0.02% | +12.5% |
| Q1 2019 | $214,000 | +0.9% | 9,549 | -5.0% | 0.02% | -15.8% |
| Q4 2018 | $212,000 | +182.7% | 10,049 | +148.2% | 0.02% | +216.7% |
| Q3 2018 | $75,000 | -16.7% | 4,049 | 0.0% | 0.01% | -25.0% |
| Q2 2018 | $90,000 | +1.1% | 4,049 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $89,000 | -5.3% | 4,049 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $94,000 | +1.1% | 4,049 | 0.0% | 0.01% | -10.0% |
| Q3 2017 | $93,000 | -30.6% | 4,049 | -33.1% | 0.01% | -37.5% |
| Q2 2017 | $134,000 | +45.7% | 6,049 | +49.4% | 0.02% | +23.1% |
| Q1 2017 | $92,000 | +3.4% | 4,049 | -5.0% | 0.01% | 0.0% |
| Q4 2016 | $89,000 | +17.1% | 4,264 | +48.9% | 0.01% | +8.3% |
| Q3 2016 | $76,000 | -3.8% | 2,864 | 0.0% | 0.01% | -7.7% |
| Q2 2016 | $79,000 | – | 2,864 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |